Please enable JavaScript to continue using this application.

Compare $BBIO vs $PCVX | Chartloom

Compare

$BBIO vs $PCVX

BridgeBio Pharma Inc · Vaxcyte Inc

BBIO

BridgeBio Pharma Inc

PCVX

Vaxcyte Inc

Compare $BBIO vs $PCVX

Comparing BridgeBio Pharma Inc and Vaxcyte Inc

BBIOBridgeBio Pharma Inc

PCVXVaxcyte Inc

BBIOBridgeBio Pharma Inc

Market cap

$12.80B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

9.67x

Rev growth (TTM)

202.4%

YTD performance

-16.5%

52W performance

18.2%

FCF yield

-3.4%

PCVXVaxcyte Inc

Market cap

$10.31B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.6%

52W performance

75.2%

FCF yield

-8.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBIO

PCVX

Detailed metrics comparison

BBIO

BridgeBio Pharma Inc

PCVX

Vaxcyte Inc

Market Cap

BBIO$12.80B

PCVX$10.31B

Enterprise Value

BBIO$15.48B

PCVX$10.12B

Price

BBIO$65.35

PCVX$71.38

P/E Ratio

BBION/A

PCVXN/A

P/S Ratio

BBIO17.95x

PCVX0.00x

EV/Sales

BBIO21.70x

PCVX0.00x

EV/EBITDA

BBIO0.00x

PCVX0.00x

P/B Ratio

BBIO227.06x

PCVX3.05x

P/FCF Ratio

BBION/A

PCVXN/A

EV/FCF

BBIO-35.35x

PCVX-10.99x

PEG Ratio

BBION/A

PCVXN/A

Forward P/E (NTM)

BBION/A

PCVXN/A

Forward P/S (NTM)

BBIO9.67x

PCVXN/A

Revenue (TTM)

BBIO$713M

PCVX$0

Revenue Growth (YoY)

BBIO202.4%

PCVXN/A

Forward Rev Growth

BBIO68.5%

PCVX157.2%

Gross Margin (TTM)

BBIO94.4%

PCVX0.0%

Operating Margin (TTM)

BBIO0.0%

PCVX0.0%

EBITDA Margin (TTM)

BBIO-66.3%

PCVX0.0%

Net Margin (TTM)

BBIO-97.0%

PCVX0.0%

FCF Margin (TTM)

BBIO-61.4%

PCVXN/A

Net Income (TTM)

BBIO$-692M

PCVX$-1.06B

FCF (TTM)

BBIO$-438M

PCVX$-921M

EPS (TTM)

BBIO-$3.53

PCVX-$7.37

ROE (TTM)

BBIO-20674.0%

PCVX-3757.0%

ROA (TTM)

BBIO-6119.0%

PCVX-3362.0%

ROIC (TTM)

BBIO-6534.0%

PCVX-3757.0%

Cash

BBIO$678M

PCVX$183M

Debt

BBIO$3.35B

PCVX$0

Net Cash/Debt

BBIO$-2.68B

PCVX$183M

Current Ratio (TTM)

BBIO1.23x

PCVX5.72x

Quick Ratio (TTM)

BBIO1.09x

PCVX5.48x

Debt/Equity (TTM)

BBIO8.27x

PCVX0.00x

Debt/Assets (TTM)

BBIO0.0%

PCVX0.0%

Interest Coverage (TTM)

BBION/A

PCVXN/A

Net Debt/EBITDA (TTM)

BBIO0.00x

PCVX0.00x

Beta

BBIO0.95

PCVX1.31

52W Performance

BBIO18.2%

PCVX75.2%

YTD Performance

BBIO-16.5%

PCVX53.6%

% from 52W High

BBIO-30.0%

PCVX-21.3%

% from 52W Low

BBIO23.9%

PCVX79.0%

Asset Turnover (TTM)

BBIO0.63x

PCVX0.00x

FCF Yield (TTM)

BBIO-3.4%

PCVX-8.9%

Earnings Yield (TTM)

BBIO-5.4%

PCVX-10.3%

Dividend Yield (TTM)

BBION/A

PCVXN/A

Rule of 40

BBIO141.0

PCVX0.0

EV/GP/RG

BBIO0.27

PCVXN/A

Ticker research

View BBIO research View PCVX research

Metric	BBIO BridgeBio Pharma Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$12.80B	$10.31B
Enterprise Value	$15.48B	$10.12B
Price	$65.35	$71.38
P/E Ratio	N/A	N/A
P/S Ratio	17.95x	0.00x
EV/Sales	21.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	227.06x	3.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-35.35x	-10.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	9.67x	N/A
Revenue & Growth
Revenue (TTM)	$713M	$0
Revenue Growth (YoY)	202.4%	N/A
Forward Rev Growth	68.5%	157.2%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.3%	0.0%
Net Margin (TTM)	-97.0%	0.0%
FCF Margin (TTM)	-61.4%	N/A
Net Income (TTM)	$-692M	$-1.06B
FCF (TTM)	$-438M	$-921M
EPS (TTM)	-$3.53	-$7.37
ROE (TTM)	-20674.0%	-3757.0%
ROA (TTM)	-6119.0%	-3362.0%
ROIC (TTM)	-6534.0%	-3757.0%
Financial Health
Cash	$678M	$183M
Debt	$3.35B	$0
Net Cash/Debt	$-2.68B	$183M
Current Ratio (TTM)	1.23x	5.72x
Quick Ratio (TTM)	1.09x	5.48x
Debt/Equity (TTM)	8.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	1.31
52W Performance	18.2%	75.2%
YTD Performance	-16.5%	53.6%
% from 52W High	-30.0%	-21.3%
% from 52W Low	23.9%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.00x
FCF Yield (TTM)	-3.4%	-8.9%
Earnings Yield (TTM)	-5.4%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	141.0	0.0
EV/GP/RG	0.27	N/A
Ticker research	View BBIO research	View PCVX research

Valuation

P/S Ratio

PCVX

0.00x

BBIO

17.95x

EV/FCF

BBIO

-35.35x

PCVX

-10.99x

Growth & revenue

Revenue Growth TTM

BBIO

202.4%

Forward Revenue Growth

PCVX

157.2%

BBIO

68.5%

Profitability & performance

Gross Margin

BBIO

94.4%

PCVX

0.0%

ROE

PCVX

-3757.0%

BBIO

-20674.0%

FCF Yield %

BBIO

-3.4%

PCVX

-8.9%

52-Week Performance

PCVX

75.2%

BBIO

18.2%

Detailed metrics comparison

BBIO

BridgeBio Pharma Inc

PCVX

Vaxcyte Inc

Market Cap

BBIO$12.80B

PCVX$10.31B

Enterprise Value

BBIO$15.48B

PCVX$10.12B

Price

BBIO$65.35

PCVX$71.38

P/E Ratio

BBION/A

PCVXN/A

P/S Ratio

BBIO17.95x

PCVX0.00x

EV/Sales

BBIO21.70x

PCVX0.00x

EV/EBITDA

BBIO0.00x

PCVX0.00x

P/B Ratio

BBIO227.06x

PCVX3.05x

P/FCF Ratio

BBION/A

PCVXN/A

EV/FCF

BBIO-35.35x

PCVX-10.99x

PEG Ratio

BBION/A

PCVXN/A

Forward P/E (NTM)

BBION/A

PCVXN/A

Forward P/S (NTM)

BBIO9.67x

PCVXN/A

Revenue (TTM)

BBIO$713M

PCVX$0

Revenue Growth (YoY)

BBIO202.4%

PCVXN/A

Forward Rev Growth

BBIO68.5%

PCVX157.2%

Gross Margin (TTM)

BBIO94.4%

PCVX0.0%

Operating Margin (TTM)

BBIO0.0%

PCVX0.0%

EBITDA Margin (TTM)

BBIO-66.3%

PCVX0.0%

Net Margin (TTM)

BBIO-97.0%

PCVX0.0%

FCF Margin (TTM)

BBIO-61.4%

PCVXN/A

Net Income (TTM)

BBIO$-692M

PCVX$-1.06B

FCF (TTM)

BBIO$-438M

PCVX$-921M

EPS (TTM)

BBIO-$3.53

PCVX-$7.37

ROE (TTM)

BBIO-20674.0%

PCVX-3757.0%

ROA (TTM)

BBIO-6119.0%

PCVX-3362.0%

ROIC (TTM)

BBIO-6534.0%

PCVX-3757.0%

Cash

BBIO$678M

PCVX$183M

Debt

BBIO$3.35B

PCVX$0

Net Cash/Debt

BBIO$-2.68B

PCVX$183M

Current Ratio (TTM)

BBIO1.23x

PCVX5.72x

Quick Ratio (TTM)

BBIO1.09x

PCVX5.48x

Debt/Equity (TTM)

BBIO8.27x

PCVX0.00x

Debt/Assets (TTM)

BBIO0.0%

PCVX0.0%

Interest Coverage (TTM)

BBION/A

PCVXN/A

Net Debt/EBITDA (TTM)

BBIO0.00x

PCVX0.00x

Beta

BBIO0.95

PCVX1.31

52W Performance

BBIO18.2%

PCVX75.2%

YTD Performance

BBIO-16.5%

PCVX53.6%

% from 52W High

BBIO-30.0%

PCVX-21.3%

% from 52W Low

BBIO23.9%

PCVX79.0%

Asset Turnover (TTM)

BBIO0.63x

PCVX0.00x

FCF Yield (TTM)

BBIO-3.4%

PCVX-8.9%

Earnings Yield (TTM)

BBIO-5.4%

PCVX-10.3%

Dividend Yield (TTM)

BBION/A

PCVXN/A

Rule of 40

BBIO141.0

PCVX0.0

EV/GP/RG

BBIO0.27

PCVXN/A

Ticker research

View BBIO research View PCVX research

Metric	BBIO BridgeBio Pharma Inc	PCVX Vaxcyte Inc
Market & Valuation
Market Cap	$12.80B	$10.31B
Enterprise Value	$15.48B	$10.12B
Price	$65.35	$71.38
P/E Ratio	N/A	N/A
P/S Ratio	17.95x	0.00x
EV/Sales	21.70x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	227.06x	3.05x
P/FCF Ratio	N/A	N/A
EV/FCF	-35.35x	-10.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	9.67x	N/A
Revenue & Growth
Revenue (TTM)	$713M	$0
Revenue Growth (YoY)	202.4%	N/A
Forward Rev Growth	68.5%	157.2%
Profitability
Gross Margin (TTM)	94.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.3%	0.0%
Net Margin (TTM)	-97.0%	0.0%
FCF Margin (TTM)	-61.4%	N/A
Net Income (TTM)	$-692M	$-1.06B
FCF (TTM)	$-438M	$-921M
EPS (TTM)	-$3.53	-$7.37
ROE (TTM)	-20674.0%	-3757.0%
ROA (TTM)	-6119.0%	-3362.0%
ROIC (TTM)	-6534.0%	-3757.0%
Financial Health
Cash	$678M	$183M
Debt	$3.35B	$0
Net Cash/Debt	$-2.68B	$183M
Current Ratio (TTM)	1.23x	5.72x
Quick Ratio (TTM)	1.09x	5.48x
Debt/Equity (TTM)	8.27x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.95	1.31
52W Performance	18.2%	75.2%
YTD Performance	-16.5%	53.6%
% from 52W High	-30.0%	-21.3%
% from 52W Low	23.9%	79.0%
Efficiency & Yields
Asset Turnover (TTM)	0.63x	0.00x
FCF Yield (TTM)	-3.4%	-8.9%
Earnings Yield (TTM)	-5.4%	-10.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	141.0	0.0
EV/GP/RG	0.27	N/A
Ticker research	View BBIO research	View PCVX research